| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
63,732 |
60,450 |
$3.63M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
41,631 |
39,097 |
$3.17M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
29,391 |
28,026 |
$2.11M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
10,199 |
9,701 |
$1.15M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
6,634 |
6,272 |
$720K |
| 87428 |
|
10,613 |
10,151 |
$371K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
9,057 |
8,751 |
$251K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
18,396 |
8,720 |
$231K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
17,510 |
16,758 |
$226K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,914 |
1,871 |
$96K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,151 |
2,072 |
$70K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,460 |
1,401 |
$62K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,923 |
3,930 |
$57K |
| 71046 |
Radiologic examination, chest; 2 views |
2,198 |
2,068 |
$54K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,507 |
1,454 |
$52K |
| 87905 |
|
1,917 |
1,794 |
$22K |
| 81025 |
|
3,215 |
3,050 |
$22K |
| 99000 |
|
13,685 |
12,613 |
$21K |
| 81003 |
|
11,195 |
10,502 |
$17K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,485 |
1,398 |
$11K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
469 |
433 |
$7K |
| 87808 |
|
994 |
875 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
2,776 |
2,590 |
$6K |
| E0114 |
Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips |
137 |
129 |
$5K |
| 73630 |
|
203 |
190 |
$5K |
| 73610 |
|
176 |
167 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
272 |
257 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,027 |
954 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
280 |
264 |
$2K |
| 93000 |
|
183 |
175 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
159 |
150 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
618 |
569 |
$945.02 |
| 73130 |
|
30 |
29 |
$863.13 |
| L4350 |
Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf |
13 |
12 |
$825.00 |
| 73560 |
|
14 |
13 |
$425.46 |
| L3260 |
Surgical boot/shoe, each |
12 |
12 |
$404.04 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
295 |
287 |
$373.33 |
| 86308 |
|
38 |
38 |
$204.38 |
| 80076 |
|
64 |
57 |
$165.86 |
| 82977 |
|
64 |
57 |
$138.96 |
| 82150 |
|
64 |
57 |
$124.72 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
145 |
135 |
$52.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
433 |
416 |
$48.91 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
200 |
189 |
$41.26 |
| 36416 |
|
93 |
86 |
$33.22 |